17 JUN 2022
What medtech start-ups need to know about protecting intellectual property
The NSW Health Commercialisation Training Program includes a one-day seminar to help start-ups understand...
16 JUN 2022
NSW medtech takes centre stage at San Diego BIO 2022
NSW’s leading research and medtech capabilities will be showcased to the world at one of the largest...
10 JUN 2022
Budget investment to accelerate RNA R&D
The NSW Government will accelerate the translation of local RNA research into new products, services...
26 MAY 2022
ZERO ramps up
The highly successful Zero Childhood Cancer program (ZERO) is opening its doors to all children with...
19 MAY 2022
Banking on early diagnosis and treatment
“By discovering novel markers and mechanisms for disease, we have the opportunity to act early and prevent...
11 MAY 2022
Bringing Novavax to Australia’s COVID-19 vaccine rollout
Sydney-based sister companies Biointelect and Biocelect have been a driving force in the rollout of the Novavax...
21 APR 2022
How solving the mystery of the mitochondrial disease diagnosis is transforming lives
Imagine that for 40 years you sought a diagnosis for your serious health condition. You battled through,...
13 APR 2022
Foundation favours the bold
The not-for-profit Snow Medical Research Foundation is investing in the next generation of scientific...
08 APR 2022
The proof of the research is in the bio-specimens
“It’s a slow process and difficult to measure, but it is not what any one person or biobank does,”...
23 MAR 2022
Australia's RNA capability strengthens as UNSW RNA Institute opens
Director of the Institute, Professor Pall Thordarson says the RNA revolution is just getting started. The...